Drug Topics

DECEMBER 22, 2022

In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.

530

530

PharmaVoice

DECEMBER 22, 2022

Art and science are often viewed as diametric opposites, but these industry insiders say their passion for painting blends into their pharma work.

276

276

Drug Topics

DECEMBER 22, 2022

Lenacapavir was approved with the FDA's Breakthrough Therapy Designation.

FDA 469

FDA 469

IDStewardship

DECEMBER 22, 2022

In this article a pediatrician puts the 2022-2023 amoxicillin shortage into perspective. . Authored By: Michael Cosimini, M.D. Article Posted 22 December 2022. There is currently a shortage of amoxicillin suspension related to increased demand in the context of a large uptick in pediatric respiratory tract infections. This is a nice time to discuss the valuable role it plays in pediatrics, and alternatives to the medication.

246

246

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 22, 2022

Eli Lilly and Company and Boehringer Ingelheim announced their SGLT2 inhibitor, empagliflozin, was associated with statistically significant reductions in HbA1c relative to placebo therapy among a population of pediatric patients with type 2 diabetes in the DINAMO trial.

464

464

PharmaVoice

DECEMBER 22, 2022

New Alzheimer's drugs are poised to change the market — and in preclinical arenas, researchers are learning more and more about the disease.

246

246

Pharmacy Times

DECEMBER 22, 2022

TD2 remission is defined as a hemoglobin A1C level of less than 6.5% at least 1 year after stopping medication, investigators say.

149

149

Drug Topics

DECEMBER 22, 2022

Stay on the nice list with these tips to help stop the spread of winter respiratory viruses.

247

247

Fierce Pharma

DECEMBER 22, 2022

Pfizer, Sanofi settle first California Zantac case slated for trial: report. zbecker. Thu, 12/22/2022 - 12:38.

137

137

Drug Topics

DECEMBER 22, 2022

Take a look back at our most popular biosimilars coverage for 2022.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

DECEMBER 22, 2022

Alex Barker founded The Happy PharmD to provide career coaching and career development classes, and since 2017, the company has helped over 1,500 pharmacists.

132

132

European Pharmaceutical Review

DECEMBER 22, 2022

Moderna, Inc. has finalised a strategic partnership with the UK government to establish a state-of-the-art mRNA vaccine research, development, and manufacturing facility in the UK. This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022. The Moderna Innovation and Technology Centre (MITC) is intended to provide access to a UK-made supply of COVID-19 jabs.

Vaccines 131

Vaccines 131

Pharmacy Times

DECEMBER 22, 2022

But many patients pay more than necessary because of PBMs, patent abuses, IQVIA data shows.

130

130

Fierce Healthcare

DECEMBER 22, 2022

Joint Commission cuts 14% of accreditation requirements for 2023, freezes fees. dmuoio. Thu, 12/22/2022 - 12:21.

116

116

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

DECEMBER 22, 2022

Significant advancements have changed the treatment landscape and clinical practice procedures.

123

123

Fierce Healthcare

DECEMBER 22, 2022

U.S. to release flu medication from Strategic National Stockpile. fdiamond. Thu, 12/22/2022 - 11:59.

116

116

Pharmacy Times

DECEMBER 22, 2022

Stephen Davis, PharmD, senior director of Health System Strategy at Shields, and Erica Diamantides, PharmD, specialty pharmacy manager at UW Medicine, discuss the current guidance and best practice for specialty pharmacy accreditations.

Specialty Pharmacies 123

Specialty Pharmacies 123

Drug Store News

DECEMBER 22, 2022

Employee well-being experts Loopin has highlighted six of the major factors in the workplace that could lead to a high staff turnover.

115

115

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

DECEMBER 22, 2022

Intravenous tocilizumab (Actemra; Genentech) has been approved for the treatment of COVID-19 in individuals who are hospitalized and receiving systemic corticosteroids and supplemental oxygen.

Hospitals 123

Hospitals FDA 123

The FDA Law Blog

DECEMBER 22, 2022

By Jeffrey N. Gibbs & Sara W. Koblitz — Back in June, when Congress was negotiating the User Fee Acts, FDA asked Congress to add in some provisions reversing several lawsuits that it had just lost. Ultimately, FDA lost that fight, and a slimmed down version of the FDA Safety and Landmark Advancements (“FDASLA”) passed without those sections. That fight has now been moved to the Appropriations Bill , where Congress is trying to integrate certain provisions that would reverse—at least in par

FDA 114

FDA Labelling 114

Drug Store News

DECEMBER 22, 2022

Disco Darling features floral, musky and fruit-infused notes that evoke the exuberance of dance, the company said.

111

111

pharmaphorum

DECEMBER 22, 2022

Four Japanese drugmakers – Astellas, Eisai, Daiichi Sankyo, and Takeda – have joined forces in a partnership intended to reduce the environmental impact of pharmaceutical packaging. The companies say they will promote the use of greener packaging for their products by sharing knowledge on technologies that can reduce their environmental impact , including blister packs made of biomass- rather than petroleum-derived plastics and more compact packaging, as well as recycled and recyclable materials

Packaging 105

Packaging 105

Drug Store News

DECEMBER 22, 2022

DSN spoke with Rachel Kreider, senior director of technical product and content design at GNC, about the biggest health and wellness trends for 2023.

103

103

STAT

DECEMBER 22, 2022

Danielle Russell is, as she says, a “poster child” for methadone. For more than a decade, the medication — one of the most effective treatments for opioid addiction — has helped her move past the heroin she used to use. She finished a series of degrees, and is now a Ph.D. student in justice studies at Arizona State University.

102

102

Digital Pharmacist

DECEMBER 22, 2022

The role of the community pharmacy has increased tremendously especially during the COVID pandemic. For pharmacies, it is important to understand the needs of the patients, and the services that patients are looking for so patient expectations can not only be met but exceeded. . In this blog, we will discuss pharmacy trends to look out for in 2023 so your business can be as prepared as possible in the New Year.

Community Pharmacies 98

Community Pharmacies Medication Delivery Compounding 98

DiversifyRx

DECEMBER 22, 2022

Dive into our top 2022 suggestions for increasing your non-PBM revenue to grow and stabilize your pharmacy profits. Last week we shared our Top 2022 Blog Resources To Increase Cash-Based Revenue , which covers our first Pharmacy Profit Pillar Cash-Based Revenue. This week we will recap the most popular blogs from 2022 that focus on non-PBM revenue. We like to differentiate non-PBM revenue from cash-based revenue.

Independent Pharmacies 98

Independent Pharmacies Insurance Patient Care 98

Drug Store News

DECEMBER 22, 2022

Flu and strep testing are administered by Giant Food's certified in-store pharmacists or certified technicians, with results received within 10 minutes.

98

98

PharmExec

DECEMBER 22, 2022

Michael Ku, VP of global clinical supply at Pfizer, shares insights for the c-suite as well as reveals behind-the-scenes insight into Pfizer’s ability to deliver a COVID-19 vaccine swiftly.

Vaccines 98

Vaccines 98

European Pharmaceutical Review

DECEMBER 22, 2022

The use of vibrational spectroscopy, including raman mapping, to study pharmaceutical products has been widely applied across the industry for several decades. 1 Conventional vibrational spectroscopic approaches, namely Raman spectroscopy, Fourier transform infrared (FTIR) spectroscopy, and near infrared (NIR) spectroscopy, are integral to providing chemical information about samples.

Labelling 98

Labelling 98

pharmaphorum

DECEMBER 22, 2022

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure that is the Chiesi Group’s new €85 million Biotech Centre of Excellence, pharmaphorum web editor Nicole Raleigh spoke with Chiesi’s head of global manufacturing, Antonio Magnelli. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting.

FDA 98

FDA 98

European Pharmaceutical Review

DECEMBER 22, 2022

Gilead-owned Kite has agreed to acquire Tmunity Therapeutics, a clinical-stage biotech focused on next-generation CAR T-therapies. The value of the transaction was not disclosed. The acquisition of Tmunity complements Kite’s existing in-house cell therapy research capabilities by adding additional pipeline assets, platform capabilities, and a strategic research and licensing agreement with the University of Pennsylvania, Specifically, it will provide Kite with rapid manufacturing processes , as

98

98

pharmaphorum

DECEMBER 22, 2022

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. Decentralised oncology trials, for example, have shown actual predictive outcome value. We can now measure patient activity, steps, and movement continuously and in real time, which serves as a new potential indicator of treatment effectiveness. 1 And, digital therapeutics have emerged as an effective treatment for chronic diseases, including mental ill

Medical Schools 97

Medical Schools FDA Patient Care 97

European Pharmaceutical Review

DECEMBER 22, 2022

Innovations in antibody design have led to an increasingly diverse range of therapeutic molecules in development including bispecific antibodies (bsAbs). Eight bispecific antibodies have been approved by the European Medicines Agency, including four novel products in 2022. 1 Such rapid expansion provides opportunities for significant therapeutic advancement.

Immunization 98

Immunization 98